NCT00905164View on ClinicalTrials.gov

Topiramate 25 mg Capsules Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

June 30, 2002

Study Completion Date

June 30, 2002

Conditions
Healthy
Interventions
DRUG

Topiramate Capsules, 25 mg

Topiramate Capsules, 2 x 25 mg

DRUG

Topamax® Capsules, 25 mg

Topamax® Capsules, 2 x 25 mg

Trial Locations (1)

G1V 2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00905164 - Topiramate 25 mg Capsules Under Fasting Conditions | Biotech Hunter | Biotech Hunter